Guangzhou Baiyunshan Pharmaceutical Holdings Company(DE:GU5)
€1.430.00 (-2.05%)
DE:GU5
Guangzhou Baiyunshan Pharmaceutical Holdings Company stock forecast
€1.43
At close:0.00 (-2.05%)
Guangzhou Baiyunshan Pharmaceutical Holdings Company (GU5) Stock Forecast & Price Target
1 Followers
GU5 Analyst Ratings
Moderate Buy
1Buy0Hold0Sell
Based on 1 analysts giving stock ratings to Guangzhou Baiyunshan Pharmaceutical Holdings Company in the past 3 months
GU5 Stock 12 Month Forecast
Average Price Target
EUR 2.35▲(64.02% Upside)Based on 1 Wall Street analysts offering 12 month price targets for Guangzhou Baiyunshan Pharmaceutical Holdings Company in the last 3 months. The average price target is EUR 2.35 with a high forecast of EUR 2.35 and a low forecast of EUR 2.35. The average price target represents a 64.02% change from the last price of EUR 1.43.
Past 12 Months12 Month ForecastJan2026Oct2026
HighEUR 2.35
AverageEUR 2.35
LowEUR 2.35
Highest Price TargetHighestEUR 2.35Average Price TargetEUR 2.35Lowest Price TargetLowestEUR 2.35
Detailed List of Analyst Forecasts
Stocks with the Highest Top Analyst Consensus in the General Sector
GU5 Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 1 | 1 | 1 | 0 |
In the current month, GU5 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. GU5 average Analyst price target in the past 3 months is 2.35.
GU5 Financial Forecast
ConsensusEUR 0.03
GU5 Earnings Forecast
Next quarter’s earnings estimate for GU5 is EUR 0.03 with a range of ― to ―. The previous quarter’s EPS was EUR 0.03. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.
ConsensusEUR 2.66B
GU5 Sales Forecast
Next quarter’s sales forecast for GU5 is EUR 2.66B with a range of ― to ―. The previous quarter’s sales results were EUR 2.66B. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.
GU5 Stock Forecast FAQ
What is DE:GU5’s average 12-month price target, according to analysts?
Based on analyst ratings, Guangzhou Baiyunshan Pharmaceutical Holdings Company’s 12-month average price target is €2.35.
What is DE:GU5’s upside potential, based on the analysts’ average price target?
Guangzhou Baiyunshan Pharmaceutical Holdings Company has 64.02% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Guangzhou Baiyunshan Pharmaceutical Holdings Company a Buy, Sell or Hold?
Guangzhou Baiyunshan Pharmaceutical Holdings Company has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Guangzhou Baiyunshan Pharmaceutical Holdings Company’s share price target?
The average share price target for Guangzhou Baiyunshan Pharmaceutical Holdings Company is €2.35. This is based on 1 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €2.35, and the lowest forecast is €2.35. The average share price target represents a 64.02% increase from the current price of €1.43.
What do analysts say about Guangzhou Baiyunshan Pharmaceutical Holdings Company?
Guangzhou Baiyunshan Pharmaceutical Holdings Company’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Street analysts.
How can I buy shares of Guangzhou Baiyunshan Pharmaceutical Holdings Company?
To buy shares of DE:GU5, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
